Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients

Lung adenocarcinoma (LUAD) represents the main lung cancer (LC) subtype that possesses a disappointing clinical outcome over the decades. Tumor hypoxia is closely bound up with dismal survival for malignant tumor cases. We identified hypoxia-associated long non-coding RNA (lncRNA) signature to be an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Jun, Zhang, Boqing, Kuai, Lin, Li, Qingguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806605/
https://www.ncbi.nlm.nih.gov/pubmed/34486476
http://dx.doi.org/10.1080/21655979.2021.1973874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806605/
https://www.ncbi.nlm.nih.gov/pubmed/34486476
http://dx.doi.org/10.1080/21655979.2021.1973874

Ejemplares similares